EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

USP33 is an integrin α6 deubiquitinase and promotes esophageal squamous cell carcinoma cell migration and metastasis

Qinglei Hang, Shiying Zuo, Yawen Yang, Yuanzhi Wang, Caimin Li, Wenqian Li, Jingya Guo, Sicong Hou, Haifeng Huang

Journal of Cancer Research and Clinical Oncology · 26.11.2024 · 150 (12)

DOI: 10.1007/s00432-024-06041-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cancer Research and Clinical Oncology, online erschienen am 26.11.2024. Verfasst von Qinglei Hang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Medicine, Medical College, Key laboratory of Jiangsu province university for Nucleic Acid & Cell Fate Manipulation, Yangzhou U…. Hauptthemen laut MEDLINE: Cell Movement, Esophageal Neoplasms, Esophageal Squamous Cell Carcinoma. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: the National Natural Science Foundation of China, the China Postdoctoral Science Foundation, the Postgraduate Research & Practice Innovation Program of Jiangsu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: The deubiquitinating enzymes (DUBs) have been linked to cancer initiation and progression. Although ubiquitin-specific protease 33 (USP33) represents a significant factor in regulating various tumor cell behaviors, its specific biological functions and precise mechanisms in esophageal squamous cell carcinoma (ESCC) progression remain unclear. METHODS: The expressions of USP33 mRNA in GEO databases, clinical ESCC samples, and USP33 protein were analyzed using bioinformatics, RT-PCR, and immunohistochemistry, respectively. Using Kaplan-Meier survival curves, the log-rank test was used to determine the cumulative survival rate. Western blotting was used to determine indicated protein expression. The cell biological functions were evaluated by cell growth assay, transwell, cell adhesion, and cell spreading assay, respectively. The interaction between USP33 and integrins was detected by immunoprecipitation, and the deubiquitination was performed by deubiquitination assay. The metastatic ability was checked by tail vein injection. RESULTS: A significant positive correlation was found between USP33 expression and clinical TNM stage, T classification, and poor prognosis in patients with ESCC. USP33 promoted laminin-dependent adhesion, spreading, and migration of ESCC cells but not their proliferation. Mechanistically, USP33 mediates cell migration through binding, deubiquinating, and stabilizing integrin α6. USP33 knockdown could inhibit ESCC cell migration and metastasis majorly through integrin α6. CONCLUSION: This study reveals a novel mechanism of USP33 in promoting laminin-dependent ESCC cell migration and metastasis through integrin α6, suggesting that USP33 may be a promising target for treating ESCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cell MovementEsophageal NeoplasmsEsophageal Squamous Cell CarcinomaHumansFemaleIntegrin alpha6PrognosisAnimalsMaleMiceCell Line, TumorCell ProliferationUbiquitin ThiolesteraseNeoplasm MetastasisCell AdhesionMice, NudeMiddle Aged

Stichwörter der Autor:innen

Esophageal squamous cell carcinomaIntegrin α6LamininMetastasisMigrationUbiquitin-specific protease 33

Substanzen

USP33 protein, humanIntegrin alpha6Ubiquitin Thiolesterase

Autor:innen und Institutionen

  • Department of Clinical Medicine, Medical College, Key laboratory of Jiangsu province university for Nucleic Acid & Cell Fate Manipulation, Yangzhou University, Yangzhou, Jiangsu Province, 225009, China. qhang@yzu.edu.cn.
  • Jiangsu Provincial Innovation and Practice Base for Postdoctors, Suining People's Hospital, Affiliated Hospital of Xuzhou Medical University, Suining, Jiangsu Province, 221200, China. qhang@yzu.edu.cn.
  • Department of Clinical Medicine, Medical College, Key laboratory of Jiangsu province university for Nucleic Acid & Cell Fate Manipulation, Yangzhou University, Yangzhou, Jiangsu Province, 225009, China.
  • Department of Gastroenterology, Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou, Jiangsu Province, 225001, China.
  • Department of Clinical Medicine, Medical College, Key laboratory of Jiangsu province university for Nucleic Acid & Cell Fate Manipulation, Yangzhou University, Yangzhou, Jiangsu Province, 225009, China. shou@yzu.edu.cn.
  • Department of Gastroenterology, Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou, Jiangsu Province, 225001, China. shou@yzu.edu.cn.

Förderung

  • the National Natural Science Foundation of China
  • the China Postdoctoral Science Foundation
  • the Postgraduate Research & Practice Innovation Program of Jiangsu Province
  • the Natural Science Foundation of Jiangsu Province
  • the General Medical Research Project of Jiangsu Provincial Health Commission
  • the Major Basic Research Project of the Natural Science Foundation of Jiangsu Higher Education Institutions of China
  • the Yancheng Municipal Health Commission Medical Science Foundation

Zitieren

APA

Hang, Q., Zuo, S., Yang, Y., Wang, Y., Li, C., Li, W., Guo, J., Hou, S., & Huang, H. (2024). USP33 is an integrin α6 deubiquitinase and promotes esophageal squamous cell carcinoma cell migration and metastasis. Journal of Cancer Research and Clinical Oncology, 150(12). https://doi.org/10.1007/s00432-024-06041-5

Vancouver

Hang Q, Zuo S, Yang Y, Wang Y, Li C, Li W, et al. USP33 is an integrin α6 deubiquitinase and promotes esophageal squamous cell carcinoma cell migration and metastasis. Journal of Cancer Research and Clinical Oncology. 2024;150(12). doi:10.1007/s00432-024-06041-5

BibTeX
@article{Hang2024,
  author = {Hang, Qinglei and Zuo, Shiying and Yang, Yawen and Wang, Yuanzhi and Li, Caimin and Li, Wenqian and Guo, Jingya and Hou, Sicong and Huang, Haifeng},
  title = {USP33 is an integrin α6 deubiquitinase and promotes esophageal squamous cell carcinoma cell migration and metastasis},
  journal = {Journal of Cancer Research and Clinical Oncology},
  year = {2024},
  volume = {150},
  number = {12},
  doi = {10.1007/s00432-024-06041-5}
}
Kostenlos starten →